FDA Drafts Guides to Speed Up Generic Drug Testing Processes
Published Date: 11/21/2025
Notice
Summary
The FDA just released new draft guides to help drug makers design studies proving their generic drugs work like the originals. If you’re in the drug business, now’s your chance to share feedback by January 20, 2026, before these guides become final. These updates aim to speed up drug approvals, potentially saving time and money for companies and patients alike!
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
Draft Guidance Aims to Speed Generics
The FDA released draft product-specific guidances that give recommendations on designing bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs). The notice says these updates aim to speed up drug approvals and could potentially save time and money for companies and patients alike; comments on the drafts are due January 20, 2026.
New Draft Guidances Posted for Many Drugs
FDA posted new draft product-specific guidances for ANDAs for listed active ingredients, including Aprocitentan, Berdazimer sodium, Budesonide, Carbidopa/Levodopa (multiple reference listed drugs), Tirzepatide, Travoprost, and others. Stakeholders may review these product-specific BE recommendations and submit comments by January 20, 2026.
Revised Draft Guidances Also Available
FDA posted revised draft product-specific guidances for ANDAs for listed active ingredients such as Aclidinium bromide, Amphetamine, Buprenorphine hydrochloride, Diazepam, Metronidazole, Valbenazine tosylate, and others. Interested parties may submit comments (including on costs or cost savings) and should do so by January 20, 2026.
Guidances Are FDA's Non-Binding Views
The draft guidances, when finalized, will represent FDA's current thinking on product-specific BE study design but do not establish any rights and are not binding. The notice explicitly says you may use an alternative approach if it satisfies applicable statutes and regulations.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in